Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “crew autonomy”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 109 records · Page 6
All sourcesNASA NTRSDOE OSTI
NASA NTRS2022

Principles for Architecting Autonomous Systems

This paper distills principles for developing autonomous systems based on experience and lessons learned from past efforts. The purpose of these principles is to establish a common understanding and knowledge of architectural elements to guide the development of next-generation multi-mission autonomous systems and ensure the safe and productive operation of space assets. An attempt has been made to ground these principles in fundamentals that should withstand the test of time while allowing for and enabling the advancement of technologies. They are not intended to prescribe a design nor a software representation. There may be multiple designs that can honor these principles. These principles are focused on autonomy for robotic assets. As such, they do not address autonomy for crewed assets nor autonomy that can collectively generate intelligent behavior without top-level system cognizance (e.g., intelligent swarm behavior). These areas would be a subject of future efforts.

Day, John↗
NASA NTRSDate not supplied

Improving Efficacy and Safety of Pharmacological Treatment Through Precision Medicine and Pharmacogenomics for Human Deep Space Exploration

INTRODUCTION: Future spaceflight will require increased crew medical autonomy as exploration class missions expanding duration and distance from Earth, especially for Mars missions. As mission duration increases, it will be even more essential to have appropriate amounts of effective medication to ensure the maintenance of crew health and performance. Conversely, mass and volume constraints will become more severe as future spaceflight expands beyond low Earth orbit, where resupply is difficult or becomes impossible. These constraints thus convey an urgency to further tailor medications included in the spacecraft formulary and increased examination of appropriate dosing regimens. BACKGROUND: Precision Health is an exciting area of cutting-edge research and medicine focused on maintaining an individual’s health and performance through in-depth understanding of an individual’s unique factors and molecular profiles. This approach can be adapted to better predict, monitor, and address physiological responses to the spaceflight environment. One example is the field of pharmacogenomics (PGX),the study of how the expressed genome impacts drug responses with the goal of prescribing the right dose of the right drug at the right time. Specifically, PGX testing provides valuable information on an individual’s precise allelic variations to guide physicians in making informed decisions on pharmaceutical choice and dosing to avoid adverse drug events and maximize pharmacological efficacy. The goal of this study was to evaluate which drugs in the current space pharmacy could be evaluated using PGX testing and to understand the potential impact on the health and wellness of the astronaut population. Additionally, we sought to evaluate clinically available FDA-approved PGX testing solutions to better understand its applicability. METHODS: A complete list of drugs onboard the International Space Station (ISS) was analyzed for risk and likelihood of drug failure and PGX actionability. This analysis encompassed both personal astronaut medications, including supplements and over the counter drugs (n=151) and ISS MedKit formulary medications (n=95). Duplicate medications and different formulations were removed, which resulted in 157 total drugs used in the subsequent analysis. A 5x5 risk assessment table was produced by examining the likelihood of drug failure compared to the consequence of drug failure. Likelihood of individual drug failure was defined by whether existing processes are sufficient to prevent adverse events, as ranked from 1 (very low, can easily be prevented) to 5 (very high, cannot be prevented) during a Mars mission. In contrast, the consequence of drug failure was defined by impact to safety, schedule, cost or technical and ranked from 1 (very low) to 5 (very high).A comprehensive assessment of commercially available PGX solutions is currently underway to evaluate specimen requirements, cost/benefit analysis (cost vs. number of alleles assessed), utility of variant analysis, relevance to inflight medication usage, quality of reporting in enabling clinical application, and ease of integration into electronic medical records. RESULTS: Risk assessments(LxC 5x5 table) indicated29medicationswere in the yellow or red zone driven predominantly by drug failure or safety concerns, with the remainder(n=128)of the medications in the green zone where risk is acceptable. We found that current PGX testing results could impact 21% of the total medications in the ISS MedKit and IMAK; of these, 9 medications currently have direct clinically actionable guidance available. Results of the clinical PGX solution evaluations as related to these medications will be presented. CONCLUSION: PGX testing has demonstrated clear benefits in terrestrial medicine and clinical environments for the selection of proper medications, avoiding adverse drug reactions, and maximizing drug efficacy. We propose that similar benefits would be bestowed on the astronaut and commercial spaceflight passenger population by performing preemptive pre-flight PGX testing to reduce risk of mission failure due to ineffective or toxic medications, improve targeting drug efficacy and safety, and further open the door to countermeasure research exploring PGX-related allelic variants. For example, PGX results could allow tailoring of specific medications at optimal doses more precisely to each individual astronaut, particularly in areas of space motion sickness, sleep aids, and analgesics. An additional benefit is that PGX results could provide information for better planning of the components of a space pharmacy for deep space missions to be more cost effective and more efficient in the utilization of limited pharmaceutical resources. Finally, while PGX testing of the astronaut corps is not currently conducted, this approach could provide immediate impact in support of mission success by reducing risks, optimizing astronaut performance, and providing valuable insights into long-term astronaut health. Such advancements in clinical decision making are important next steps in building dynamic individual risk profiles for astronauts, increasing crew autonomy and providing tailored countermeasures

Alice R W Tang↗
NASA NTRS2018

Spacecraft Dormancy Autonomy Analysis for a Crewed Martian Mission

Current concepts of operations for human exploration of Mars center on the staged deployment of spacecraft, logistics, and crew. Though most studies focus on the needs for human occupation of the spacecraft and habitats, these resources will spend most of their lifetime unoccupied. As such, it is important to identify the operational state of the unoccupied spacecraft or habitat, as well as to design the systems to enable the appropriate level of autonomy. Key goals for this study include providing a realistic assessment of what "dormancy" entails for human spacecraft, exploring gaps in state-of-the-art for autonomy in human spacecraft design, providing recommendations for investments in autonomous systems technology development, and developing architectural requirements for spacecraft that must be autonomous during dormant operations. The mission that was chosen is based on a crewed mission to Mars. In particular, this study focuses on the time that the spacecraft that carried humans to Mars spends dormant in Martian orbit while the crew carries out a surface mission. Communications constraints are assumed to be severe, with limited bandwidth and limited ability to send commands and receive telemetry. The assumptions made as part of this mission have close parallels with mission scenarios envisioned for dormant cis-lunar habitats that are stepping-stones to Mars missions. As such, the data in this report is expected to be broadly applicable to all dormant deep space human spacecraft.

Badger, Julia↗
NASA NTRS2019

Training for Long-Duration Space Missions: A Literature Review into Skill Retention and Generalizability

In long-duration space missions, skill retention and generalizability become ever more important as mission length increases, for it is through these capabilities that astronaut crews achieve autonomy. A framework is proposed for future research based on three types of training commonly found in operational scenarios: initial training, refresher training, and just-in-time training. One of the key points of interest identified from the body of literature is the need for a structured and quantifiable approach to characterize skill decay. Such an approach would allow gaining a deeper understanding of the mechanisms through which skill decay operates. Because simulators are used extensively in all types of training, the effects of simulator fidelity on skill retention and generalizability are paramount to understand. Some common fidelity types are defined and their effects on the human operator are discussed. From a review of the literature on all these topics, several research gaps were identified that led to three key opportunities for future research: (1) developing skill decay functions provides theoretical insights into skill decay and allows for several practical applications, such as planning refresher training, (2) the effects of simulator fidelity on skill decay functions should be investigated empirically, and (3) investigating the generalizability of skills learned in initial training to other tasks could provide space crews with greater autonomy. A cybernetic approach might give new insights.

training↗
NASA NTRS2019

Training for Long-Duration Space Missions: A Literature Review into Skill Retention and Generalizatility

In long-duration space missions, skill retention and generalizability become ever more important as mission length increases, for it is through these capabilities that astronaut crews achieve autonomy. A framework is proposed for future research based on three types of training commonly found in operational scenarios: initial training, refresher training, and just-in-time training. One of the key points of interest identified from the body of literature is the need for a structured and quantifiable approach to characterize skill decay. Such an approach would allow gaining a deeper understanding of the mechanisms through which skill decay operates. Because simulators are used extensively in all types of training, the effects of simulator fidelity on skill retention and generalizability are paramount to understand. Some common fidelity types are defined and their effects on the human operator are discussed. From a review of the literature on all these topics, several research gaps were identified that led to three key opportunities for future research: (1) developing skill decay functions provides theoretical insights into skill decay and allows for several practical applications, such as planning refresher training, (2) the effects of simulator fidelity on skill decay functions should be investigated empirically, and (3) investigating the generalizability of skills learned in initial training to other tasks could provide space crews with greater autonomy. A cybernetic approach might give new insights.

Pieters, Marc A.↗
NASA NTRS2008

Lunar and Mars Exploration: The Autonomy Factor

Long duration space flight crews have relied heavily on almost constant communication with ground control mission support. Ground control teams provide vehicle status and system monitoring, while offering near real time support for specific tasks, emergencies, and ensuring crew health and well being. With extended exploration goals to lunar and Mars outposts, real time communication with ground control teams and the ground s ability to conduct mission monitoring will be very limited compared to the resources provided to current International Space Station (ISS) crews. An operational shift toward more autonomy and a heavier reliance on the crew to monitor their vehicle and operations will be required for these future missions. NASA s future exploration endeavors and the subsequent increased autonomy will require a shift in crew skill composition, i.e. engineer, doctor, mission specialist etc. and lead to new training challenges and mission scenarios. Specifically, operational and design changes will be necessary in many areas including: Habitat Infrastructure and Support Systems, Crew Composition, Training, Procedures and Mission Planning. This paper will specifically address how to apply ISS lessons learned to further use ISS as a test bed to address decreased amounts of ground support to achieve full autonomous operations for lunar and Mars missions. Understanding these lessons learned and applying them to current operations will help to address the future impacts of increased crew autonomy for the lunar and Mars outposts and pave the way for success in increasingly longer mission durations.

Rando, Cynthia M.↗
NASA NTRSDate not supplied

NASA’s Moon to Mars (M2M) Transit Habitat Refinement Point of Departure Design

As NASA prepares for the next human footsteps on the lunar surface, the Agency is already looking ahead to systems that will enable a sustained human presence on the lunar surface and mission to Mars, including a lunar Surface Habitat (SH) and Mars Transit Habitat (TH). This paper describes the latest NASA government reference design for the TH and how it will support NASA's Moon to Mars human exploration architecture. First, it will serve as a test and demonstration platform in lunar orbit, demonstrating capabilities required for long-duration microgravity human spaceflight as part of the lunar-Mars analog missions. Then, the TH will serve as a major Mars exploration element to support crew habitation during their transit from the Earth’s orbit to Mars and returning safely before TH’s return to a lunar orbit. This paper will cover several considerations contributing to the latest habitat design refinement, including the TH's concept of operations, system functional definition, subsystem assumptions, notional interior layouts, a detailed mass and volume breakdown, and identify future trade studies and analyses required to close identified technology/ development/architecture gaps. In addition to a technical description of the TH, this paper describes how the current TH government reference design will achieve many of the current lunar and Mars mission goals. Additionally, there are many assumed technological advances needed to support the prescribed mission phases leading up to the crewed mission to Mars in the late 2030s. The paper will describe many of the TH systems requiring further technology development and identify architectural solutions to achieve these mass, reliability, autonomy, and crew health targets. As a whole, the data shows the government reference TH design meeting the 26.4 metric ton launch /trans-Mars injection burn control mass limit outlined within NASA’s Moon to Mars Campaign. This is achievable near the desired timeframe with moderate strategic investments including maintainable life support systems, innovative structures configuration and materials, and system/ logistics packaging. The resulting design detail and data contained in this paper are intended to help teams across NASA and potential commercial, academic, or international partners understand the current performance targets of the Transit Habitat and vehicle interface considerations imposed by the latest Moon to Mars mission scope.

Habitation Systems↗
NASA NTRSDate not supplied

NASA’s Moon to Mars (M2M) Transit Habitat (TH) Refinement Point of Departure (PoD) Design

As NASA prepares for the next human footsteps on the lunar surface, the Agency is already looking ahead to systems that will enable a sustained human presence on the lunar surface and mission to Mars, including a lunar Surface Habitat and Mars Transit Habitat (TH). This paper describes the latest NASA government reference design for the TH and how it will support NASA's Moon to Mars human exploration architecture. First, it will serve as a test and demonstration platform in lunar orbit, demonstrating capabilities required for long-duration microgravity human spaceflight as part of the lunar-Mars analog missions. Then, the TH will also serve as a major Mars habitation exploration element to support the crew during their transit from the lunar orbit to Mars and returning them safely to lunar orbit. This paper will cover several considerations contributing to the latest habitat design refinement, including data on the TH's concept of operations, system functional definition, subsystem assumptions, notional interior layouts, a detailed mass and volume breakdown, and trade studies and analyses required to close identified technology/ development/architecture gaps. In addition to a technical description of the TH, this paper describes how the current TH government reference design will achieve many of the current lunar and Mars mission goals. Additionally, there are many assumed technological advances needed to support the prescribed mission phases leading up to the crewed mission to Mars in the late 2030s. The paper will describe many of the TH systems requiring further technology development and identify architectural solutions to achieve these mass, reliability, autonomy, and crew health targets. As a whole, the data in the paper shows that a TH meeting the 43 metric tons launch mass/trans-Mars injection burn limits specified by the Evolvable Mars Campaign is achievable near the desired timeframe with moderate strategic investments including maintainable life support systems, re-purposable structures and packaging, and lightweight exercise modalities. It also identifies operational and technological options to reduce this mass to less than 41 metric tons, including staging of launch structure/packaging and alternate structural materials. The resulting design detail and data contained in this paper are intended to help teams across NASA and potential commercial, academic, or international partners understand the current performance targets of the Transit Habitat and vehicle interface considerations imposed by the latest Moon to Mars mission scope.

Habitation Systems↗
NASA NTRSDate not supplied

Improving Efficacy and Safety of Pharmacological Treatment Through Precision Health and Pharmacogenomics

INTRODUCTION: Future spaceflight will require increased crew medical autonomy as exploration class missions expand in duration and distance from Earth, especially for Mars missions. As mission duration increases, it will be essential to have appropriate amounts of effective medication to ensure the maintenance of crew health and performance. Conversely, mass and volume constraints will become more severe as future spaceflight expands beyond low Earth orbit, where resupply is difficult or becomes impossible. These constraints thus convey an urgency to tailor medications for individual crewmembers and further examine appropriate dosing regimens. BACKGROUND: Precision Health is an exciting area of medicine focused on maintaining an individual’s health and performance through in-depth understanding of an individual’s unique clinical and environmental history, genetic makeup, and molecular profiles. This approach can be adapted to better predict, monitor, and address physiological responses to the spaceflight environment. A subset of this field is pharmacogenomics (PGX), the study of how the expressed genome impacts drug responses with the goal of prescribing the right dose of the right drug at the right time. Specifically, PGX testing provides valuable information on an individual’s precise allelic variations to guide physicians in making informed decisions on drug choice and dosing to avoid adverse events and maximize efficacy. The study goal was to identify which current space pharmacy drugs could be evaluated using PGX testing and to understand the potential impact on the health and wellness of the astronaut population. Additionally, we sought to evaluate clinically available FDA-approved PGX testing solutions to better understand its applicability. METHODS: A complete list of drugs on the ISS was analyzed for risk and likelihood of drug failure and PGX actionability. This analysis encompassed both astronauts’ personal medications, including supplements and over the counter drugs (n=151) contained in the ISS medical accessory kit (IMAK), and ISS MedKit formulary medications (n=95). Duplicate medications and different formulations were removed, which resulted in a total of 157 drugs used in the subsequent analysis. A 5x5 risk assessment table was produced by examining the likelihood of drug failure compared to the consequence of drug failure (LxC). Likelihood of individual drug failure was defined by whether existing processes are sufficient to prevent ineffective treatment or impactful side effect events, as ranked from 1 (very low, can easily be prevented) to 5 (very high, cannot be prevented) during a Mars mission. In contrast, the consequence of drug failure was defined by impact to safety, schedule, cost, or technical criteria and ranked from 1 (very low) to 5 (very high). An assessment of PGX reference laboratories is currently underway to evaluate sample requirements, benefit analysis (cost vs. utility of allele variant analysis), relevance to inflight medication usage, quality of reporting in enabling clinical application, and ease of integration into electronic medical records. RESULTS: Risk assessments (LxC 5x5 table) indicated 128 medications were in the green zone where risk is acceptable, with the remaining 29 of the medications in the yellow or red zone driven predominantly due to drug failure or safety concerns. We found that current PGX testing results could impact 21% of the total medications in the ISS MedKit and IMAK; of these, 9 medications currently have direct clinically actionable guidance available. Results of the clinical PGX solution evaluations as related to these medications will be presented. CONCLUSION: PGX testing has demonstrated clear benefits in terrestrial medicine and clinical environments for the selection of proper medications, avoiding adverse drug reactions, and maximizing drug efficacy. We propose that similar benefits would be bestowed on the astronaut and commercial spaceflight passenger population by performing preemptive preflight PGX testing to reduce risk of mission failure due to ineffective or toxic medications, improve drug efficacy, and further open the door to countermeasure research. For example, PGX results could allow tailoring of specific medications at optimal doses more precisely to each individual astronaut, particularly in areas of space motion sickness, sleep aids, and analgesics. An additional benefit is that PGX results could provide information for better planning of the components of a space pharmacy for deep space missions to be more effective and efficient in the utilization of limited pharmaceutical resources. Finally, while PGX testing of the astronaut corps is not currently conducted, this approach could provide immediate impact in support of mission success by reducing risks, optimizing astronaut performance, and providing valuable insights into long-term astronaut health. Such advancements in clinical decision making are important next steps in building dynamic individual risk profiles for astronauts, increasing selection of the best treatment choice, and providing tailored countermeasures for individual crewmembers.

Pharmacogenomics↗
NASA NTRS2024

ISS Technology Demonstrations for Future Spaceflight Medical Systems

Throughout the history of human spaceflight, crewmembers have experienced various in-flight medical conditions including illness and injury. Planned missions to the Moon and Mars will require capabilities to maintain the health of future space travelers. Mass, power, and volume available in the vehicles and habitats for these missions will be severely constrained; resupply of resources will be limited or non-existent, as will opportunities for evacuation to Earth. Furthermore, ground-based support will be hampered by communication latencies and blackouts. These vehicle and mission constraints will necessitate a medical system that has been efficiently planned, providing on-board procedural guidance in addition to a variety of medical devices and consumable resources. Medical capabilities required for the diagnosis and treatment of potential medical conditions during future spaceflight missions may include real-time health monitoring, medical imaging, and biomarker analyses ( e.g., blood or urine). Terrestrial medicine shares these needs, thus many of these medical capabilities could likely be satisfied by Commercial-Off-The-Shelf (COTS) devices and methodologies; however, in some cases the unique space environment and increased mission duration will drive the need to modify technologies and the way care is provided. NASA’s Human Research Program (HRP) Exploration Medical Capability (ExMC) Element and Mars Campaign Office’s Exploration Medical Integrated Product Team (XMIPT) are working together to decrease medical risk during exploration missions. Flight-tested medical diagnostic and treatment technologies are necessary to effectively manage medical conditions relevant to exploration missions while meeting vehicle constraints, integrating with medical decision-support tools, and enabling increasingly Earth-independent operations. Several projects have leveraged the ISS as a testbed for exploration, including 1) i n- situ blood analysis, 2) medical inventory, 3) intravenous fluid generation, and 4) autonomous medical procedure guidance. Management of several in-flight medical conditions, such as bacterial and viral infections and acute radiation syndrome, is dramatically improved with ability to assess blood cell populations, electrolytes, and metabolites. I n December 2020 and January 2021 ExMC performed an ISS technology demonstration (Tech Demo) of the HemoCue® WBC DIFF analyzer (HemoCue, Brea, CA), a COTS device that was modified to enable functionality in a spaceflight environment. This Tech Demo marked the first time that hematology measurements were successfully performed real-time in microgravity. Also modified and demonstrated was the reusable Handheld Electrolytes and Lab Technology for Humans (rHEALTH) ONE analyzer (rHEALTH, Bedford, MA), which uses flow cytometry and sheath-based hydrodynamic focusing methodologies. The rHEALTH ONE ISS Tech Demo in May 2022 demonstrated test results obtained in-flight matched those on the ground. NASA currently relies on crew self-reporting to manage and maintain medical inventory on ISS.The ability to maintain an accurate inventory becomes more critical during long duration missions since the crew will need to be increasingly autonomous in finding and utilizing medical items, including those scenarios when alternative treatments need to be considered due to limited or no resupply. HRP’s Medical Consumables Tracking (MCT) project was developed by ZIN Technologies, Inc. (Cleveland, OH), and demonstrated real-time tracking of medical supplies aboard the ISS between December 2016 and July 2018. The MCT system design utilized Radio Frequency Identification Device (RFID) technology to perform automated inventory and was installed in the Crew Health Care System (CHeCS) Resupply Stowage Rack (RSR). The challenge of limited shelf life, exacerbated by the lack of resupply opportunities, affects a plethora of medical system components including consumables, pharmaceuticals, and intravenous (IV) fluid. In 2010, ExMC funded ZIN Technologies, Inc. (Cleveland, OH), to develop the Intravenous Fluid Generation (IVGEN) system. IV fluids were successfully generated with IVGEN using the potable water supply on ISS during ISS Expedition 23. The XMIPT is in the process of developing a miniaturized version of the original IVGEN hardware for a future Tech Demo aboard the ISS. Current ISS medical operations rely heavily on preflight training and real-time remote guidance, both of which become impractical or impossible for exploration missions. The primary goal of the Autonomous Medical Officer Support (AMOS) Software Tech Demos on ISS was to confirm telemedical proof-of-concept for autonomous medical imaging in an operational setting. This novel software tool shifts emphasis from preflight training and real-time remote guidance to in-flight just-in-time instruction, a new and necessary paradigm for crew medical autonomy. AMOS introduces a novel, streamlined skill management concept for exploration missions featuring comprehensive training and guidance modules for ultrasound examinations using the ISS Ultrasound 2 (a modified GE Vivid-q™; General Electric HealthCare, Chicago, IL). With no prior crew training or remote guidance, two Tech Demos on the ISS (April 2020 and June 2022) resulted in high quality, clinically useful image sets. We will provide a review of historical, current, and planned medical devices and technologies considered for inclusion within future spaceflight medical systems and summarize hardware development activities and medical device tech demos conducted on the ISS.

Astronaut health and performance↗
NASA NTRS2018

Low-Latency Teleoperations: Operational Implications for Human Space Exploration

Low-latency teleoperations (LLT) is envisioned to be an element of human exploration missions in a number of different applications. LLT can be broadly considered to encompass any remote operation of an asset with a communication delay that is less than the human response time to allow for what is effectively "real-time" or "near real-time" operations. This paper will explore motivations and operational implications for why and how LLT might be used for human exploration space missions. LLT analyses have been performed under the auspices of the NASA Human Spaceflight Architecture Team (HAT) and Evolvable Mars Campaign (EMC). The EMC created a flexible, evolvable, capability-driven architectural strategy to enable a sustainable long-term human presence at Mars. LLT is envisioned to be part of that strategy for both in-space and on-surface applications, and this paper will expand on operational considerations within that broader strategic context, as well additional contexts. Some operational implications explored in this paper, derived largely from previous work, are: (1) crew mission support, for which we will address roles for Mission Control on earth, balanced with the capability for crew and robotic assets to operate independently, (2) science operations, with a focus on "backroom" support, highly dynamic science, and enhanced science return and efficiency, and (3) operational efficiency at a deep-space destination such as Mars, including implications for communications infrastructures and how to leverage and balance system autonomy with crew operations, both of which can inform the overall operational "choreography" between crew members, multiple shifts, and exploration assets.

human spaceflight↗
NASA NTRSDate not supplied

Autonomous Medical Officer Support (AMOS) ISS Technology Demonstration: Enabling Earth-Independnt Procedure Guidance

Successful performance of medical procedures during missions beyond low Earth orbit requires novel solutions to replace real-time support from the ground since the communication delay will be longer as the crew travels farther from Earth. The Autonomous Medical Officer Support software Technology Demonstration project (AMOS Tech Demo) on the International Space Station (ISS) evaluates a novel software tool that shifts the emphasis from preflight training and real-time guidance (current ISS paradigm) to in-flight just-in-time (JIT) instruction (a new paradigm for crew medical autonomy). The AMOS platform introduces a novel, streamlined, skill-management archetype for exploration missions; the current AMOS version features comprehensive training and guidance modules for urinary bladder and kidney ultrasound examinations. The primary goal of the AMOS Tech Demo was to confirm telemedical proof-of-concept through initial use of the platform for autonomous imaging activities in an operational setting. Success metrics encompassed 1) successful software deployment, 2) collection of click tracking data, and 3) recording of ultrasound images. Additional aims included collecting crew feedback on a) AMOS implementation, and b) integrated training and procedure support concepts, as well as c) evaluation of AMOS use in an operational setting.

D. Ebert↗
NASA NTRS2000

Controlling Microbial Byproducts using Model-Based Substrate Monitoring and Control Strategies

We have developed a computer-controlled bioreactor system to study various aspects of microbially-mediated nitrogen cycling. The system has been used to investigate methods for controlling microbial denitrification (the dissimilatory reduction of nitrate to N2O and N2) in hydroponic plant growth chambers. Such chambers are key elements of advanced life support systems being designed for use on long duration space missions, but nitrogen use efficiency in them is reduced by denitrification. Control software architecture was designed which permits the heterogeneous control of system hardware using traditional feedback control, and quantitative and qualitative models of various system features. Model-based feed forward control entails prediction of future systems in states and automated regulation of system parameters to achieve desired and avoid undesirable system states. A bacterial growth rate model based on the classic Monod model of saturation kinetics was used to evaluate the response of several individual denitrifying species to varying environmental conditions. The system and models are now being applied to mixed microbial communities harvested from the root zone of a hydroponic growth chamber. The use of a modified Monod organism interaction model was evaluated as a means of achieving more accurate description of the dynamic behavior of the communities. A minimum variance parameter estimation routine was also' used to calibrate the constant parameters in the model by iterative evaluation of substrate (nitrate) uptake and growth kinetics. This representation of processes and interactions aids in the formulation of control laws. The feed forward control strategy being developed will increase system autonomy, reduce crew intervention and limit the accumulation of undesirable waste products (NOx).

Smernoff, David T.↗
NASA NTRS2005

Autonomous Systems, Robotics, and Computing Systems Capability Roadmap: NRC Dialogue

Contents include the following: Introduction. Process, Mission Drivers, Deliverables, and Interfaces. Autonomy. Crew-Centered and Remote Operations. Integrated Systems Health Management. Autonomous Vehicle Control. Autonomous Process Control. Robotics. Robotics for Solar System Exploration. Robotics for Lunar and Planetary Habitation. Robotics for In-Space Operations. Computing Systems. Conclusion.

Zornetzer, Steve↗
NASA NTRS2015

The ISECG* Global Exploration Roadmap as Context for Robotic and Human Exploration Operations

The International Space Exploration Coordination Group (ISECG) Global Exploration Roadmap (GER) provides a broad international context for understanding how robotic missions and robotic assets can enable future human exploration of multiple destinations. This presentation will provide a brief high-level review of the GER with a focus on key robotic missions and robotic assets that can provide enabling technology advancements and that also raise interesting operational challenges in both the near-term and long-term. The GER presently features a variety of robotic missions and robotic assets that can provide important technology advancements as well as operational challenges and improvements, in areas ranging from: (a) leveraging the International Space Station, (b) planetary science robotic missions to potential human destinations, (c) micro-g body proximity operations (e.g. asteroids), (d) autonomous operations, (e) high and low-latency telerobotics, (f) human assisted sample return, and (g) contamination control. This presentation will highlight operational and technology challenges in these areas that have feed forward implications for human exploration.

telerobotics↗
NASA NTRS2015

Low-Latency Teleoperations for Human Exploration and Evolvable Mars Campaign

NASA has been analyzing a number of mission concepts and activities that involve low-latency telerobotic (LLT) operations. One mission concept that will be covered in this presentation is Crew-Assisted Sample Return which involves the crew acquiring samples (1) that have already been delivered to space, and or acquiring samples via LLT from orbit to a planetary surface and then launching the samples to space to be captured in space and then returned to the earth with the crew. Both versions of have key roles for low-latency teleoperations. More broadly, the NASA Evolvable Mars Campaign is exploring a number of other activities that involve LLT, such as: (a) human asteroid missions, (b) PhobosDeimos missions, (c) Mars human landing site reconnaissance and site preparation, and (d) Mars sample handling and analysis. Many of these activities could be conducted from Mars orbit and also with the crew on the Mars surface remotely operating assets elsewhere on the surface, e.g. for exploring Mars special regions and or teleoperating a sample analysis laboratory both of which may help address planetary protection concerns. The operational and technology implications of low-latency teleoperations will be explored, including discussion of relevant items in the NASA Technology Roadmap and also how previously deployed robotic assets from any source could subsequently be used by astronauts via LLT.

crew autonomy↗
NASA NTRS2021

Novel Ways to use the International Spacer Station as an Exploration Analog: International Progress in Planning "ISS4Mars"

In October 2020, International Space Station (ISS) Partner Agencies held a set of international workshops to solicit and develop creative and forward-looking ideas for using the ISS as an analog for preparation for Mars missions during its 3rd decade of operations. The workshops brought together participants from nine international space agencies or organizations, with stakeholders consisting of research managers, discipline experts, technology developers, flight physicians, flight operators, and astronauts. Breakout meetings and brainstorming sessions were conducted focusing on the following topics: Critical hazards and countermeasures for the transit to Mars; gravity transitions and early surface operations; environmental control and life support systems; food systems; human microbiome, microbial monitoring, and planetary protection; medical operations for Mars missions; isolation and confinement; autonomous systems and crew-centered autonomy; and communications delay effects on operations. In many cases the scenarios and approaches identified were compelling but challenging to implement under the current utilization structure used to manage the ISS for experiments. Following the series of workshops, a team of utilization leaders across the ISS partnership worked to compile the workshop recommendations and extract a set of use-cases with their prerequisites and constraints. The work considered the following aspects: what can be effectively done on ISS; which new technologies, approaches and scenarios are feasible; what alternatives could be considered; and what steps should be taken to enable integrated testing and future use of ISS as an analog for Mars missions. The final report will be published so that the use cases can be considered in each agency’s strategic planning processes. This paper will cover the process of international assessment in detail and how this process has influenced and broadened the vision of ISS utilization beyond single experiments to integrated studies and testing for future Mars missions. This approach to international collaboration informs both the next decade of international exploration research on the ISS and advancement of its utilization as an analog for deep space missions. For many of the participating partners, it also helps to frame the strategy for human research in Artemis as we begin planning for human missions to the moon. We conclude with a summary of the progress on the actions in the report and the additional implementation discussions that have occurred across the partnership.

Julie A Robinson↗
NASA NTRSDate not supplied

Environmental Control and Life Support (ECLS) System Options for Mars Transit and Mars Surface Missions

The NASA led Artemis campaign will take humanity back to the Moon and serve as an analog for continued deep space exploration to Mars. Artemis utilizes crewed vehicles and habitats on both the Lunar surface and in Lunar orbit. The exploration of the Lunar surface and buildup of a basecamp is meant to be a “Mars forward” approach to testing and refining new technologies and techniques for living and working far outside of Low Earth Orbit (LEO) and preparing for future Mars missions. The Lunar Surface Habitat is planned as a primary element for long duration crew habitation on the Moon and will be the primary testbed for ECLS system hardware in a partial gravity environment. The Mars Transit Habitat will be the crew vehicle for the roundtrip from Earth to Mars and spend a significant amount of time docked to the Gateway outfitting and testing its systems prior to making the first Mars mission transit. The Mars Transit Habitat will utilize closed loop ECLS system technologies while a Mars Surface Habitat could use either open loop, closed loop, or a mix of both. Better understanding the needs of both these system architectures operating for extended periods in the Lunar environment and outside LEO will help to establish the ECLS system architecture for the future Mars surface mission. There are many aspects to consider such as length of crew stay, level of autonomy and dormancy between crewed missions, power requirements, system mass, and overall system reliability and maintainability. Other considerations will include Mars gravity vs. Lunar gravity, Mars atmospheric pressure vs. hard vacuum, and possible use of in-situ resource utilization.

ECLSS↗